Baxter International, a company that develops, manufactures, and markets products that save and sustain the lives of people, is set to spin-off its Renal Care and Acute Therapies businesses. “We are confident that the strategic actions we are announcing today will help ensure that each of these entities, and the incredibly strong and dedicated group of colleagues that comprise them, are on the best possible trajectory moving forward. Realizing the full impact of these decisions will take time, but we believe they are essential to enhance our focus, fuel our innovative spirit, and, most crucially, deliver optimal results for the patients, clinicians, shareholders, and other stakeholder communities that depend on us,” José Almeida, Baxter Chairman, President and CEO.